THE CHALLENGE OF FOLLOW-ON BIOLOGICS FOR TREATMENT OF MULTIPLE SCLEROSIS

被引：1

|

作者：

Rivera, Victor M.

机构：

来源：

NEUROLOGY | 2010年 / 74卷 / 10期

关键词：

D O I：

10.1212/WNL.0b013e3181d2b209

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：864 / 864

页数：1

相关论文

共 50 条

[41] Follow-on biologics: data exclusivity and the balance between innovation and competition
Henry Grabowski
Nature Reviews Drug Discovery, 2008, 7 : 479 - 488
[42] Global follow-on biologics - IBC's fifth annual conference
Wheelwright, Scott M.
IDRUGS, 2008, 11 (02) : 94 - 96
[43] No Longer "If," But "When": The Coming Abbreviated Approval Pathway for Follow-on Biologics
Kelly, Jeremiah J.
David, Michael
FOOD AND DRUG LAW JOURNAL, 2009, 64 (01) : 115 - 148
[44] BIOT 174-Scientific developments in the follow-on biologics debate
Moreira, Antonio R.
Hanson, Michael A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[45] Emerging Experience with Follow-On Biologics: Active Surveillance and Risk Management
Morris, Jon
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S267 - S267
[46] Follow-on biologics: data exclusivity and the balance between innovation and competition
Grabowski, Henry
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 479 - 488
[47] Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics
Zhang, Nan
Yang, Jun
Chow, Shein-Chung
Endrenyi, Laszlo
Chi, Eric
STATISTICS IN MEDICINE, 2013, 32 (03) : 424 - 433
[48] Biosimilar epoetins and other "follow-on'' biologics: Update on the European experiences
Jelkmann, Wolfgang
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) : 771 - 780
[49] Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
J. Michael Nicholas
Drug information journal : DIJ / Drug Information Association, 2012, 46 : 197 - 206
[50] Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
Nicholas, J. Michael
DRUG INFORMATION JOURNAL, 2012, 46 (02): : 197 - 206

← 1 2 3 4 5 →